Non-vitamin K antagonist oral anticoagulants may be even more effective for treating women with atrial fibrillation (AFib) than men, suggests a real-world study from Hong Kong published in the Journal of the American College of Cardiology.
The more a person smokes, the greater the risk of developing a heart rhythm disorder, according to a new study published July 11 in the European Journal of Preventive Cardiology.
Blacks who survive in-hospital cardiac arrest (IHCA) are 28 percent less likely to live to one year after discharge and 33 percent less likely to survive five years when compared to white counterparts, suggesting a disparity in follow-up care.
Individuals at high risk for atrial fibrillation (AFib) who utilized a home-based wearable electrocardiogram (ECG) patch had a higher rate of AFib diagnosis after four months compared to delayed monitoring.
July 09, 2018 | Vascular & Endovascular
Nonsteroidal anti-inflammatory drugs (NSAIDs) can be dangerous for patients with atrial fibrillation (AFib) when taken on top of oral anticoagulants, suggests a post hoc analysis of the RE-LY trial published in the Journal of the American College of Cardiology.
Boston Scientific plans to acquire Cryterion Medical, a company developing a single-shot cryoablation platform to treat patients with atrial fibrillation (AFib). Already an investor in the company, Boston Scientific will purchase the remaining 65 percent stake for $202 million in up-front cash.
A federal investigation into the potential overuse of primary prevention implantable cardioverter defibrillators (ICDs) appears to have made hospitals more judicious in their use of the devices, according to a study published July 3 in the Journal of the American Medical Association.
July 03, 2018 | Imaging
Two neurologists from Stanford University believe their specialty must take the lead on ensuring patients with cardiovascular implantable electronic devices (CIEDs) have access to MRI when necessary.
June 28, 2018 | Acute Coronary Syndrome
Compared to warfarin, the direct oral anticoagulants (DOACs) apixaban, rivaroxaban and dabigatran are all associated with a reduced risk of myocardial infarction, according to a Danish registry study of consecutive patients with nonvalvular atrial fibrillation (AFib).
The thinking behind the Seattle Proportional Risk Model goes like this: As the annual risk for all-cause mortality increases, the likelihood that the death will be sudden—or something an ICD could prevent—goes down.
A triple therapy approach of warfarin, clopidogrel and aspirin substantially reduces the risk of ischemic stroke and stent thrombosis compared to dual antiplatelet therapy (DAPT), according to a meta-analysis of patients with atrial fibrillation (AFib) undergoing coronary stenting. However, the three-medication strategy is associated with a higher bleeding risk.
June 22, 2018 | Heart Failure
Continuing cardiac resynchronization therapy (CRT) appeared to offer no benefit to patients who received a continuous flow left ventricular assist device (CF-LVAD), according to a multicenter study published in the Journal of the American Heart Association.
About 40 percent of deaths attributed to sudden cardiac arrest (SCA) aren’t really from “sudden” or heart-related causes, according to an autopsy study conducted in the San Francisco area.
Patients who progressed to having longer episodes of subclinical atrial fibrillation (SCAF) were more than four times as likely to be hospitalized for heart failure in a one-year span, according to a study published June 4 in the Journal of the American College of Cardiology.
People who reported having stressful jobs were 48 percent more likely to develop atrial fibrillation (AFib), according to a Swedish study published in the European Journal of Preventive Cardiology.
With shorter half-lives and more predictable effects, direct oral anticoagulants (DOACs) could help simplify perioperative treatment decisions for patients with non-valvular atrial fibrillation (NVAF), suggests a meta-analysis published May 24 in Circulation.
Vascular & Endovascular, Electrophysiology & Arrhythmia
Patients who required permanent pacemakers (PPMs) after transcatheter aortic valve replacement (TAVR) demonstrated lower survival rates and higher comorbidity burdens over a multiyear follow-up. However, they didn’t accumulate significantly greater healthcare costs, according to a study published online May 25 in JAMA Network Open.
Electrophysiology & Arrhythmia, Structural & Congenital Heart Disease, Healthcare Economics & Policy
Pfizer gave more than $10 million to a charity for heart patients while dramatically increasing the price of one of its antiarrhythmic drugs, deflecting costs from patients and leaving Medicare with a bigger bill, the U.S. Justice Department said in a May 24 settlement statement.
Healthcare Economics & Policy, Electrophysiology & Arrhythmia
A smartwatch algorithm reliably differentiated atrial fibrillation (AF) from sinus rhythm among patients scheduled for elective cardioversion, showing the technology’s potential to prevent unnecessary procedures.
Electrophysiology & Arrhythmia
May 23, 2018 | Practice Management
Pregnancy increases the risk of morbidity in women who exhibit cardiovascular disease (CVD). Complications in expecting mothers may be predicted by a risk index that integrates lesion-specific, delivery-of-care and generic variables.
Practice Management, Acute Coronary Syndrome, Electrophysiology & Arrhythmia
Haider Warraich, MD, used the recently presented CABANA trial to launch into an opinion piece about the medical community’s eagerness to embrace new technologies and invasive procedures.
Healthcare Economics & Policy, Electrophysiology & Arrhythmia